A
$ Value
$0
Shares
33,662
Price
$0
Filed
Jun 6
Insider
Name
Ho Carole
Title
—
CIK
0001724605
Roles
Director
Transaction Details
Transaction Date
2025-06-04
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,662
Footnotes
The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.
Filing Info
Ho Carole's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-13 | DNLI | ▼ | $12K |
| 2025-08-12 | DNLI | ▼ | $40K |
| 2025-08-05 | DNLI | M | $30K |
| 2025-08-05 | DNLI | M | $0 |
| 2025-07-31 | RPRX | A | $0 |
| 2025-07-31 | RPRX | A | $0 |
| 2025-06-04 | BEAM | A | $0 |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $1.9M | 2026-04-01 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Emany Sravan Kumar
Chief Financial Officer
|
— | — | 2026-03-31 |
|
Bellon Christine
Chief Legal Officer
|
— | $146K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | $80K | 2026-04-01 |